Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Orwick, Shelley J.
96  Ergebnisse:
Personensuche X
?
1

Pyrimidine depletion enhances targeted and immune therapy c..:

Elgamal, Ola A. ; Fobare, Sydney ; Vibhute, Sandip...
JCI Insight.  9 (2024)  8 - p. , 2024
Link: https://doi.org/10.1172/..
 
?
2

The multi-CDK inhibitor dinaciclib reverses bromo- and extr..:

Marr, Alexander R. ; Halpin, Madeline ; Corbin, Dominique L....
Experimental Hematology & Oncology.  13 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Sex-associated differences in frequencies and prognostic im..:

Ozga, Michael ; Nicolet, Deedra ; Mrózek, Krzysztof...
Leukemia.  38 (2023)  1 - p. 45-57 , 2023
Link: https://doi.org/10.1038/..
 
?
4

Framework of clonal mutations concurrent with WT1 mutations..:

Bhatnagar, Bhavana ; Kohlschmidt, Jessica ; Orwick, Shelley J....
Blood Advances.  7 (2023)  16 - p. 4671-4675 , 2023
Link: https://doi.org/10.1182/..
 
?
5

Outcome prediction by the 2022 European LeukemiaNet genetic..:

Mrózek, Krzysztof ; Kohlschmidt, Jessica ; Blachly, James S....
Leukemia.  37 (2023)  4 - p. 788-798 , 2023
Link: https://doi.org/10.1038/..
 
?
6

Association of social deprivation with survival in younger ..:

Rebechi, Melanie ; Kohlschmidt, Jessica ; Mrózek, Krzysztof...
Blood Advances.  7 (2023)  15 - p. 4019-4023 , 2023
Link: https://doi.org/10.1182/..
 
?
7

Microenvironmental control of hematopoietic stem cell fate ..:

Binder, Vera ; Li, Wantong ; Faisal, Muhammad...
Cell Reports.  42 (2023)  5 - p. 112528 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETIN..:

Mims, Alice ; Huang, Ying ; Eisenmann, Eric...
HemaSphere.  7 (2023)  S3 - p. e2938119 , 2023
Link: https://doi.org/10.1097/..
 
?
9

Molecular, clinical, and prognostic implications of PTPN11 ..:

Fobare, Sydney ; Kohlschmidt, Jessica ; Ozer, Hatice Gulcin...
Blood Advances.  6 (2022)  5 - p. 1371-1380 , 2022
Link: https://doi.org/10.1182/..
 
?
10

BMX kinase mediates gilteritinib resistance inFLT3-mutated ..:

Buelow, Daelynn R. ; Bhatnagar, Bhavana ; Orwick, Shelley J....
Blood Advances.  6 (2022)  17 - p. 5049-5060 , 2022
Link: https://doi.org/10.1182/..
 
?
11

Clonal hematopoiesis of indeterminate potential in the comp..:

Sebastian, Kimberley ; Özer, H. Gülçin ; Howard, Cory...
Leukemia.  36 (2022)  5 - p. 1401-1403 , 2022
Link: https://doi.org/10.1038/..
 
?
12

High early death rates, treatment resistance, and short sur..:

Larkin, Karilyn T. ; Nicolet, Deedra ; Kelly, Benjamin J....
Blood Advances.  6 (2022)  19 - p. 5570-5581 , 2022
Link: https://doi.org/10.1182/..
 
?
13

TP-0903 Is Active in Preclinical Models of Acute Myeloid Le..:

Eisenmann, Eric D. ; Stromatt, Jack C. ; Fobare, Sydney...
Cancers.  15 (2022)  1 - p. 29 , 2022
Link: https://doi.org/10.3390/..
 
?
14

VIP152 is a selective CDK9 inhibitor with pre-clinical in v..:

Sher, Steven ; Whipp, Ethan ; Walker, Janek...
Leukemia.  37 (2022)  2 - p. 326-338 , 2022
Link: https://doi.org/10.1038/..
 
?
15

Preclinical Characterization of TP‐0903, a Novel Multikinas..:

Eisenmann, Eric ; Fobare, Sydney ; Huang, Kevin...
The FASEB Journal.  35 (2021)  S1 - p. , 2021
Link: https://doi.org/10.1096/..
 
1-15